When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study
ContributorsCain, Lauren E; Logan, Roger; Robins, James M; Sterne, Jonathan A C; Sabin, Caroline; Bansi, Loveleen; Justice, Amy; Goulet, Joseph; van Sighem, Ard; de Wolf, Frank; Bucher, Heiner C; von Wyl, Viktor; Esteve, Anna; Casabona, Jordi; del Amo, Julia; Moreno, Santiago; Seng, Remonie; Meyer, Laurence; Perez-Hoyos, Santiago; Muga, Roberto; Lodi, Sara; Lanoy, Emilie; Costagliola, Dominique; Hernan, Miguel A; Wyler, Claire-Anne
Published inAnnals of internal medicine, vol. 154, no. 8, p. 509-515
Publication date2011
Abstract
Keywords
- Acquired Immunodeficiency Syndrome/drug therapy/immunology/mortality
- Anti-Retroviral Agents/administration & dosage/therapeutic use
- CD4 Lymphocyte Count
- Cause of Death
- Developed Countries
- Disease Progression
- Drug Administration Schedule
- Drug Therapy, Combination
- HIV Infections/drug therapy/immunology/mortality
- Humans
- Observation
- Proportional Hazards Models
- Prospective Studies
Affiliation entities
Citation (ISO format)
CAIN, Lauren E et al. When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. In: Annals of internal medicine, 2011, vol. 154, n° 8, p. 509–515. doi: 10.1059/0003-4819-154-8-201104190-00001
Main files (1)
Article (Published version)
Identifiers
- PID : unige:25797
- DOI : 10.1059/0003-4819-154-8-201104190-00001
- PMID : 21502648
Journal ISSN0003-4819
